Perception of risk from tobacco use is lower among cancer survivors who smoke
the ONA take:
A new study identified several factors that inhibit the efforts of cancer survivors who smoke to quit. In the study, cancer survivors who smoke reported fewer negative opinions about smoking, have more barriers to quitting, and are around other smokers more often than survivors who quit before or after their diagnosis.
The researchers report that patients with cancers strongly linked to smoking, such as lung and head and neck, had high initial quit rates; however, many relapse and begin smoking again. Quit rates are not high among patients with other cancers. Researchers feel they may not realize the connection between their cancer and smoking, or they did not receive advice or follow-up assistance in regard to smoking cessation.
The analysis also revealed that survivors who currently smoked reported more daily exposure to others who smoke. The researchers say this is a factor that needs to be considered when counseling patients about quitting smoking. They suggest that exposure to other smokers should be addressed when counseling patients with cancer to quit.
A new study identified several factors that inhibit the efforts of cancer survivors who smoke to quit.
- Response to Anemia Treatment Differs in Lymphoma, Multiple Myeloma
- Fertility Preservation in Male Adolescents and Young Adults With Cancer
- Impact of Prostate Cancer Diagnosis, Treatment Choice on Quality of Life
- Social, Psychiatric Variables Reduce Cognitive Functioning, QoL in HNC
- Axillary Lymph Node Dissection Predictive for Lymphedema in Breast Cancer
- HPV and Cancer (Fact Sheet)
- Pain Control More Easily Achieved With Nurse-Led Education in Bone Metastases
- Acupuncture an Effective Alternative Treatment for Cancer-Related Fatigue
- Using Nutrition-Based Strategies to Manage Adverse Effects of Cancer
- Palliative Care Associated With Decreased Costs For Patients With Advanced Cancer
- Colorectal Cancer and Dietary Fiber: Source Is More Important Than Amount
- Reduced Delayed Intensification Impacts Risk of Pediatric ALL Relapse
- Exercise May Mitigate Cardiotoxicity Associated With Doxorubicin Treatment
- Mobile Health Apps Becoming More Popular Among Patients and Clinicians
- Online Learning Modules Improve Exercise Counseling, But Not Participation
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|